P21 as a transcriptional co-repressor of S-phase and mitotic control genes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ferrándiz, Nuria ^a,g   Caraballo, Juan M ^a   García Gutierrez, Lucía ^a   Devgan, Vikram ^b   Rodriguez Paredes, Manuel ^c   Lafita, M Carmen ^a   Bretones, Gabriel ^a   Quintanilla, Andrea ^a   Muñoz Alonso, M Jose ^a,d   Blanco, Rosa ^a   Reyes, Jose C ^c   Agell, Neus ^e   Delgado, M Dolores ^a   Dotto, G Paolo ^b,f   León, Javier ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CSIC   (Spain)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; LUCIFERASE; MESSENGER RNA;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; CCNE2 GENE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL STRAIN K 562; CHROMATIN IMMUNOPRECIPITATION; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE REPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; MITOSIS; MUTATIONAL ANALYSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

CELL LINE; CLUSTER ANALYSIS; CO-REPRESSOR PROTEINS; COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; KERATINOCYTES; MITOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; S PHASE; TRANSCRIPTION, GENETIC;

EID: 84861477671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037759     Document Type: Article

References (48)

1. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
2. Gu Y, Turck CW, Morgan DO, (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
3. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, et al. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
4. Serrano M, Hannon GJ, Beach D, (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
5. Bates S, Ryan KM, Phillips AC, Vousden KH, (1998) Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 17: 1691-1703.
6. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, et al. (1998) Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18: 629-643.
7. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, et al. (2000) p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19: 2165-2170.
8. Munoz-Alonso MJ, Ceballos L, Bretones G, Frade P, Leon J, et al. (2011) MYC accelerates p21(CIP)-induced megakaryocytic differentiation involving early mitosis arrest in leukemia cells. J Cell Physiol 227: 2069-2078.
9. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, et al. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P, (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
11. Efeyan A, Collado M, Velasco-Miguel S, Serrano M, (2007) Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression. Oncogene 26: 1645-1649.
12. Weiss RH, (2003) p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4: 425-429.
13. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K, (2007) The multiple battles fought by anti-apoptotic p21. Cell Cycle 6: 407-413.
14. Gartel AL, Tyner AL, (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
15. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, et al. (2000) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 97: 4291-4296.
16. Pantoja C, Serrano M, (1999) Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18: 4974-4982.
17. Iglesias-Ara A, Zenarruzabeitia O, Fernandez-Rueda J, Sanchez-Tillo E, Field SJ, et al. (2010) Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21(CIP1)-dependent senescence. Oncogene 29: 5579-5590.
18. Munoz-Alonso M, Leon J, (2003) G1 phase control and cell differentiation. In: Boonstra J, editors. G1 phase progression New York Landes Bioscience pp. 1-29.
19. Dotto GP, (2000) p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43-56.
20. Perkins ND, (2002) Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). Cell Cycle 1: 39-41.
21. Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, et al. (2009) Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 34: 663-673.
22. Delavaine L, La Thangue NB, (1999) Control of E2F activity by p21Waf1/Cip1. Oncogene 18: 5381-5392.
23. Devgan V, Mammucari C, Millar SE, Brisken C, Dotto GP, (2005) p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19: 1485-1495.
24. Vigneron A, Cherier J, Barre B, Gamelin E, Coqueret O, (2006) The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 281: 34742-34750.
25. Devgan V, Nguyen BC, Oh H, Dotto GP, (2006) p21WAF1/Cip1 suppresses keratinocyte differentiation independently of the cell cycle through transcriptional up-regulation of the IGF-I gene. J Biol Chem 281: 30463-30470.
26. Poole JC, Thain A, Perkins ND, Roninson IB, (2004) Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. Cell Cycle 3: 931-940.
27. Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M, (2005) p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol Cell Biol 25: 2419-2430.
28. Snowden AW, Anderson LA, Webster GA, Perkins ND, (2000) A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. Mol Cell Biol 20: 2676-2686.
29. Martin A, Odajima J, Hunt SL, Dubus P, Ortega S, et al. (2005) Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 7: 591-598.
30. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, et al. (2006) Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 20: 1028-1042.
31. Munoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, et al. (2005) p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 280: 18120-18129.
32. Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, et al. (1998) Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280: 1069-1072.
33. Rodriguez-Vilarrupla A, Diaz C, Canela N, Rahn HP, Bachs O, et al. (2002) Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. FEBS Lett 531: 319-323.
34. Li C, Wong WH, (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
35. van Betteraey-Nikoleit M, Eisele KH, Stabenow D, Probst H, (2003) Analyzing changes of chromatin-bound replication proteins occurring in response to and after release from a hypoxic block of replicon initiation in T24 cells. Eur J Biochem 270: 3880-3890.
36. Vaque JP, Fernandez-Garcia B, Garcia-Sanz P, Ferrandiz N, Bretones G, et al. (2008) c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation. Mol Cancer Res 6: 325-339.
37. Ohtani K, DeGregori J, Nevins JR, (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A 92: 12146-12150.
38. Rodriguez-Paredes M, Ceballos-Chavez M, Esteller M, Garcia-Dominguez M, Reyes JC, (2009) The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res 37: 2449-2460.
39. Delgado MD, Vaque JP, Arozarena I, Lopez-Ilasaca MA, Martinez C, et al. (2000) H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism. Oncogene 19: 783-790.
40. Besson A, Dowdy SF, Roberts JM, (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14: 159-169.
41. Li B, Carey M, Workman JL, (2007) The role of chromatin during transcription. Cell 128: 707-719.
42. Luo Y, Hurwitz J, Massague J, (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161.
43. Ferrandiz N, Caraballo JM, Albajar M, Gomez-Casares MT, Lopez-Jorge CE, et al. (2010) p21(Cip1) confers resistance to imatinib in human chronic myeloid leukemia cells. Cancer Lett 292: 133-139.
44. Zhu H, Chang BD, Uchiumi T, Roninson IB, (2002) Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1). Cell Cycle 1: 59-66.
45. Lohr K, Moritz C, Contente A, Dobbelstein M, (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278: 32507-32516.
46. Maclaren A, Clark W, Black EJ, Gregory D, Fujii H, et al. (2003) v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1. Oncogene 22: 2383-2395.
47. Muller GA, Engeland K, (2009) The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription. Febs J 277: 877-893.
48. Pippa R, Espinosa L, Gundem G, Garcia-Escudero R, Dominguez A, et al. (2012) p27(Kip1) represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene In press.